Weight loss as a treatment for nonalcoholic fatty liver disease.
about
Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayNonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Role of diet and lifestyle changes in nonalcoholic fatty liver diseaseFructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia.Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention programEffects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.NAFLD, Estrogens, and Physical Exercise: The Animal ModelNon-alcohol fatty liver disease in Asia: Prevention and planning.A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.Proteomics Analysis to Identify and Characterize the Molecular Signatures of Hepatic Steatosis in Ovariectomized Rats as a Model of Postmenopausal StatusDietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional studyThe Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialA Randomized Controlled Trial of the Effects of an Almond-enriched, Hypocaloric Diet on Liver Function Tests in Overweight/Obese Women.The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review.Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus.Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease.Assessment of the relationship between non-alcoholic fatty liver disease and CAD using MSCT.Dietary and Behavioral Approaches in the Management of Obesity.Practical management of the increasing burden of non-alcoholic fatty liver disease.The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
P2860
Q26800894-7BF1A827-174D-4D07-891A-D4EA72E8A9EAQ33409801-9FD858A7-1FB4-4A22-A037-E713EF0EA0DEQ33563333-5C1F91E2-41BB-4B1C-B630-B8F9BFB6D0FDQ33948329-B527FA71-93DA-4A04-BC7D-DA7A8E69B7F4Q34056163-796E416D-9F19-43D1-9FFD-CE960A1278F2Q34168532-43FEB8EE-2A4F-44F9-BFBF-B3C403B27201Q34460590-1796DA5A-8B4D-4D87-B56F-5E4906688E04Q34648009-90D78850-ECDE-4F0A-9A93-F52EE796CB43Q35031260-D9D8A74D-0E59-453F-9FCC-5481714058BBQ35090416-40636BF8-6A02-4D5A-A520-1737B541B278Q35101309-BF786266-C553-4B9F-9AC5-CB76F5BE40C8Q35103678-621C0B22-FB83-4F0F-8DBC-D643A93B072DQ35159321-EC934179-FAB6-43A8-8A01-AD05F9E4583FQ35819344-8EF28DB5-EBEF-4721-A0B9-5A52FFA414E7Q36172470-611306E7-96BC-4D52-8F7A-A4A73CC0FAFFQ36246843-9290B0E3-291E-4B5F-946A-C2AB62C9A624Q36555004-F2A1D2C8-10C6-4976-A807-BF237C7CC619Q36732958-7B348B53-A9BB-4AEC-AD5D-F14391C093FFQ36934465-1E5FA684-7451-4CFE-AADD-05E5BCFA7A1CQ37233319-55B6DF1C-CC76-42B2-923F-0528BB74C5C2Q37375539-B6287D69-3278-47C8-9DE0-26572968D9CDQ37416574-11A5F239-8F1A-4E23-BE26-ABD4BF44E475Q37658856-77DA206A-4C72-437D-8E4E-7AB0D8223DACQ37664577-A1A5626B-28B1-4B2F-9C58-61C1996984EAQ37703921-8103DAEB-EC63-40C0-A2F8-0A87E9461C2FQ39006276-C67E70E2-5F33-4D6C-9282-A1A9B85F4144Q41059980-AEB12D83-27AE-4ECB-B882-F0DB6A7CE6C2Q41172779-4BF9AC7A-C18D-4F28-859E-5B1935DA3386Q41815307-8083B8E9-8859-4CDB-99C9-887503EA81EC
P2860
Weight loss as a treatment for nonalcoholic fatty liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Weight loss as a treatment for nonalcoholic fatty liver disease.
@ast
Weight loss as a treatment for nonalcoholic fatty liver disease.
@en
type
label
Weight loss as a treatment for nonalcoholic fatty liver disease.
@ast
Weight loss as a treatment for nonalcoholic fatty liver disease.
@en
prefLabel
Weight loss as a treatment for nonalcoholic fatty liver disease.
@ast
Weight loss as a treatment for nonalcoholic fatty liver disease.
@en
P1476
Weight loss as a treatment for nonalcoholic fatty liver disease.
@en
P2093
Jeanne M Clark
P304
P356
10.1097/01.MCG.0000168641.31321.FA
P478
40 Suppl 1
P577
2006-03-01T00:00:00Z